135 related articles for article (PubMed ID: 29974765)
1. Visceral adiposity increases the risk of breast cancer: a case-control study.
Godinho-Mota JCM; Martins KA; Vaz-Gonçalves L; Mota JF; Soares LR; Freitas-Junior R
Nutr Hosp; 2018 Jun; 35(3):576-581. PubMed ID: 29974765
[TBL] [Abstract][Full Text] [Related]
2. Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance.
Mazidi M; Kengne AP; Katsiki N; Mikhailidis DP; Banach M
J Diabetes Complications; 2018 Mar; 32(3):266-270. PubMed ID: 29395839
[TBL] [Abstract][Full Text] [Related]
3. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
[TBL] [Abstract][Full Text] [Related]
4. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
Anik Ilhan G; Yildizhan B; Pekin T
Gynecol Endocrinol; 2019 Mar; 35(3):233-236. PubMed ID: 30303693
[TBL] [Abstract][Full Text] [Related]
5. Are visceral adiposity index and lipid accumulation product reliable indices for metabolic disturbances in patients with type 2 diabetes mellitus?
Kavaric N; Klisic A; Ninic A
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28632304
[TBL] [Abstract][Full Text] [Related]
6. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB
Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188
[TBL] [Abstract][Full Text] [Related]
7. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance.
Du T; Yuan G; Zhang M; Zhou X; Sun X; Yu X
Cardiovasc Diabetol; 2014 Oct; 13():146. PubMed ID: 25326814
[TBL] [Abstract][Full Text] [Related]
8. Association Between the Visceral Adiposity Index and Homeostatic Model Assessment of Insulin Resistance in Participants With Normal Waist Circumference.
Ji B; Qu H; Wang H; Wei H; Deng H
Angiology; 2017 Sep; 68(8):716-721. PubMed ID: 28743220
[TBL] [Abstract][Full Text] [Related]
9. Can Visceral Adiposity Index Serve as a Simple Tool for Identifying Individuals with Insulin Resistance in Daily Clinical Practice?
Štěpánek L; Horáková D; Cibičková Ľ; Vaverková H; Karásek D; Nakládalová M; Zapletalová J
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31470593
[No Abstract] [Full Text] [Related]
10. Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women.
dos Santos RE; Aldrighi JM; Lanz JR; Ferezin PC; Marone MM
Gynecol Endocrinol; 2005 Nov; 21(5):295-301. PubMed ID: 16373250
[TBL] [Abstract][Full Text] [Related]
11. Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype.
Du T; Yu X; Zhang J; Sun X
Acta Diabetol; 2015 Oct; 52(5):855-63. PubMed ID: 25690647
[TBL] [Abstract][Full Text] [Related]
12. Independent association between the visceral adiposity index and microalbuminuria in patients with newly diagnosed type 2 diabetes.
Wen J; Yuan H
Diabetes Metab Res Rev; 2020 Jan; 36(1):e3198. PubMed ID: 31228226
[TBL] [Abstract][Full Text] [Related]
13. Assessment of visceral adiposity index and lipid accumulation product index as markers of chronic kidney disease among diabetic and hypertensive patients at the Bamenda Regional Hospital, Cameroon: a cross-sectional study.
Choumessi AT; Saha BUF; Navti LK; Tibi AS; Njeck AT; Nantia EA
Pan Afr Med J; 2022; 42():228. PubMed ID: 36845245
[TBL] [Abstract][Full Text] [Related]
14. Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study.
Ramezani Tehrani F; Minooee S; Azizi F
Eur J Endocrinol; 2014 Aug; 171(2):199-207. PubMed ID: 24816947
[TBL] [Abstract][Full Text] [Related]
15. New indexes of body fat distribution, visceral adiposity index, body adiposity index, waist-to-height ratio, and metabolic disturbances in the obese.
Jabłonowska-Lietz B; Wrzosek M; Włodarczyk M; Nowicka G
Kardiol Pol; 2017; 75(11):1185-1191. PubMed ID: 28715064
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between visceral obesity and atherosclerosis in hemodialysis patients].
He PH; Min YL; Zhou CM; Tong XY; Lin X; Li Q; Zha Y
Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(42):3411-3414. PubMed ID: 30440135
[No Abstract] [Full Text] [Related]
17. Visceral adiposity index and lipid accumulation product as a predictor of type 2 diabetes mellitus: The Bogor cohort study of non-communicable diseases risk factors.
Nusrianto R; Ayundini G; Kristanti M; Astrella C; Amalina N; Muhadi ; Riyadina W; Tahapary DL; Soewondo P
Diabetes Res Clin Pract; 2019 Sep; 155():107798. PubMed ID: 31330161
[TBL] [Abstract][Full Text] [Related]
18. Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease.
Petta S; Amato MC; Di Marco V; Cammà C; Pizzolanti G; Barcellona MR; Cabibi D; Galluzzo A; Sinagra D; Giordano C; Craxì A
Aliment Pharmacol Ther; 2012 Jan; 35(2):238-47. PubMed ID: 22117531
[TBL] [Abstract][Full Text] [Related]
19. Lipid Accumulation Product Is More Related to Insulin Resistance than the Visceral Adiposity Index in the Maracaibo City Population, Venezuela.
Bermúdez V; Salazar J; Fuenmayor J; Nava M; Ortega Á; Duran P; Rojas M; Añez R; Rivas-Montenegro A; Angarita L; Chacín M; Cano C; Velasco M; Rojas J
J Obes; 2021; 2021():5514901. PubMed ID: 34194826
[TBL] [Abstract][Full Text] [Related]
20. The Role of Visceral Adiposity Index Levels in Predicting the Presence of Metabolic Syndrome and Insulin Resistance in Overweight and Obese Patients.
Pekgor S; Duran C; Berberoglu U; Eryilmaz MA
Metab Syndr Relat Disord; 2019 Jun; 17(5):296-302. PubMed ID: 30932744
[No Abstract] [Full Text] [Related]
[Next] [New Search]
